Sixty-one high-risk (cT2-T4aN ≤ 1) operable cis-eligible patients with UC were further subdivided into “hot” and “cold” tumor groups based on an 18-gene interferon (IFN)-gamma signaling-based tumor inflammation signature (TIS) [72]. This evidence concerns the gene IFNG and neoplasm.